Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r*,r*)-(+-)-2,3-dihydroxybutanedioic Acid, Monoammonium Monosodium Salt
2. Aluminum Tartrate
3. Ammonium Tartrate
4. Calcium Tartrate
5. Calcium Tartrate Tetrahydrate
6. Mn(iii) Tartrate
7. Potassium Tartrate
8. Seignette Salt
9. Sodium Ammonium Tartrate
10. Sodium Potassium Tartrate
11. Sodium Tartrate
12. Stannous Tartrate
13. Tartaric Acid
14. Tartaric Acid, ((r*,r*)-(+-))-isomer
15. Tartaric Acid, (r*,s*)-isomer
16. Tartaric Acid, (r-(r*,r*))-isomer
17. Tartaric Acid, (s-(r*,r*))-isomer
18. Tartaric Acid, Ammonium Sodium Salt, (1:1:1) Salt, (r*,r*)-(+-)-isomer
19. Tartaric Acid, Calcium Salt, (r-r*,r*)-isomer
20. Tartaric Acid, Monoammonium Salt, (r-(r*,r*))-isomer
21. Tartrate
1. Faecula
2. Faecla
3. Acid Potassium Tartrate
4. Faccula
5. Faccla
6. Tartar
7. Potassium L-bitartrate
8. Tartar Cream
9. Monopotassium Tartrate
10. Cream Of Tartar
11. Potassium Hydrogentartrate
12. Purified Cream Of Tartar
13. Npt6p8p3uu
14. Butanedioic Acid, 2,3-dihydroxy- (2r,3r)-, Monopotassium Salt
15. Potassium Tartrate
16. Ins No.336(i)
17. Ins-336(i)
18. Monopotassium Tartrate (336(i))
19. Cremor Tartari
20. E-336(i)
21. Butanedioic Acid 2,3-dihydroxy-, (r-(r*,r*))-, Monopotassium Salt
22. Potassium L-tartrate
23. Potassium (2r,3r)-3-carboxy-2,3-dihydroxypropanoate
24. Potassium Hydrogen Tartrate (jan)
25. Potassium Hydrogen Tartrate [jan]
26. Potassium Tartrate (khc4h4o6)
27. Tartaric Acid, Monopotassium Salt
28. Nsc-155080
29. Potassium Bitartrate [usan]
30. Potassium Hydrogen L-tartrate
31. Potassium L-tartrate Monobasic
32. Ccris 7329
33. Potassium Acid Salt Of L-(+)-tartaric Acid
34. Tartaric Acid Monopotassium Salt
35. Hsdb 1264
36. Potassium L-tartrate (kc4h5o6)
37. Einecs 212-769-1
38. L(+)-tartaric Acid Monopotassium Salt
39. Nsc 155080
40. Unii-npt6p8p3uu
41. Potassium Bitartrate (usp)
42. Schembl39256
43. L(+)-potassiumhydrogentartrate
44. Chembl2105248
45. Dtxsid6042313
46. Monopotassium 2,3-dihydroxybutanedioate, (r-(r*,r*))-
47. Chebi:32034
48. Potassium Hydrogen (+)-tartrate
49. Potassium Bitartrate [ii]
50. Potassium Bitartrate [mi]
51. Potassium Bitartrate [usan:usp]
52. Potassium Bitartrate [inci]
53. Potassium Bitartrate [vandf]
54. Butanedioic Acid, 2,3-dihydroxy-, (r-(r*,r*))-, Monopotassium Salt
55. Mfcd00065392
56. Potassium Bitartrate [usp-rs]
57. Potassium Bitartrate [who-dd]
58. Akos015915093
59. Butanedioic Acid, 2,3-dihydroxy- (theta-(theta,theta))-, Monopotassium Salt
60. Db11107
61. Potassium Acid Tartrate [mart.]
62. E336
63. Potassium Bitartrate [orange Book]
64. Potassium Bitartrate [usp Impurity]
65. Potassium Bitartrate [usp Monograph]
66. D01561
67. Ec 212-769-1
68. Potassium Hydrogen Tartrate [ep Impurity]
69. Potassium Hydrogen Tartrate [ep Monograph]
70. Butanedioic Acid, 2,3-dihydroxy- (2r,3r)-, Potassium Salt (1:1)
| Molecular Weight | 188.18 g/mol |
|---|---|
| Molecular Formula | C4H5KO6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 187.97231936 g/mol |
| Monoisotopic Mass | 187.97231936 g/mol |
| Topological Polar Surface Area | 118 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 157 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Indicated for the treatment of constipation.
Potassium bitartrate potentiates bowel movements. In medical studies, it was shown to be an effective treatment for chronic constipationwhen combined with sodium bicarbonate in a polyethylene glycol-based suppository.
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12B - Potassium
A12BA - Potassium
A12BA03 - Potassium hydrogentartrate
Absorption
There is little systemic absorption expected following rectal administration of potassium bitartrate.
Route of Elimination
No pharmacokinetic data available.
Volume of Distribution
No pharmacokinetic data available.
Clearance
No pharmacokinetic data available.
No pharmacokinetic data available.
No pharmacokinetic data available.
Potassium bitartrate is a carbon dioxide-releasing laxative that works by forming carbon dioxide gas, which creates a mechanical distension against the intestinal wall and induces bowel contractions. Rectal suppositories of carbon dioxide-releasing type of laxative were demonstrated to be useful and safe in the treatment of patients at risk for electrolyte disorders such as the elderly or patients with renal or cardiovascular disorders.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
